Cargando…

Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study

INTRODUCTION: Inhaled corticosteroids (ICSs) are recommended for patients with frequent exacerbation of chronic obstructive pulmonary disease (COPD). However, accumulating evidence has indicated the risk of pneumonia from the use of ICS. This study aimed to investigate the association between ICS an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji-Ho, Park, You Hyun, Kang, Dae Ryong, Lee, Seok Jeong, Lee, Myoung Kyu, Kim, Sang-Ha, Yong, Suk Joong, Lee, Won-Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778438/ https://www.ncbi.nlm.nih.gov/pubmed/33402820 http://dx.doi.org/10.2147/COPD.S286149

Ejemplares similares

Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Pulmonary Disease in Chronic Obstructive Pulmonary Disease: Findings from a Nationwide Population-Based Study
por: Yu, Iseul, et al.
Publicado: (2023)

Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia
por: Shin, Beomsu, et al.
Publicado: (2018)

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi, Jae-Hwa, et al.
Publicado: (2021)

The Efficacy of Immediate Diet for Reducing Local Adverse Events of Inhaled Corticosteroid: A Pilot Study
por: Lee, Myoung Kyu, et al.
Publicado: (2012)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Adherence to Long-Acting Inhaler Use for Initial Treatment and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
por: Suh, Hee-Sook, et al.
Publicado: (2022)

Polysomnographic phenotype as a risk factor for cardiovascular diseases in patients with obstructive sleep apnea syndrome: a retrospective cohort study
por: Park, Sunmin, et al.
Publicado: (2020)

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD
por: Lee, Hyo Jin, et al.
Publicado: (2022)

Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
por: Lee, Ye Jin, et al.
Publicado: (2023)

Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
por: Jo, Yong Suk, et al.
Publicado: (2020)

Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study
por: Lee, Ming-Chia, et al.
Publicado: (2015)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

A Prediction Scoring Model for the Effect of Withdrawal or Addition of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease
por: Lee, Jang Ho, et al.
Publicado: (2023)

Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015)

Recurred Post-intubation Tracheal Stenosis Treated with Bronchoscopic Cryotherapy
por: Jung, Ye-Ryung, et al.
Publicado: (2016)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
por: Lee, Se Hee, et al.
Publicado: (2019)

Association between airflow limitation and prognosis in patients with chronic pulmonary aspergillosis
por: Lee, Myoung Kyu, et al.
Publicado: (2021)

Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
por: Kim, Sang-Heon
Publicado: (2019)

Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan
por: Chiu, Kai-Lin, et al.
Publicado: (2021)

Risk Factors Related with Mortality in Patient with Pulmonary Tuberculosis
por: Kim, Chong Whan, et al.
Publicado: (2012)

Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan
por: Hirano, Ryosuke, et al.
Publicado: (2018)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

Safety and Utility of Rush Immunotherapy with Aqueous Allergen Extracts for Treatment of Respiratory Allergies
por: Lee, Ji-Ho, et al.
Publicado: (2020)

Pleural fluid ADA activity in tuberculous pleurisy can be low in elderly, critically ill patients with multi-organ failure
por: Kim, Sae Byol, et al.
Publicado: (2020)

Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
por: Jung, Ho Yeon, et al.
Publicado: (2018)

Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
por: Yu, Iseul, et al.
Publicado: (2022)

A Case of Autoimmune Progesterone Dermatitis Misdiagnosed as Allergic Contact Dermatitis
por: Lee, Myoung Kyu, et al.
Publicado: (2011)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

The association of delta neutrophil index with the prognosis of acute exacerbation of chronic obstructive pulmonary disease
por: Park, Sunmin, et al.
Publicado: (2020)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
por: Lineros, Rosario, et al.
Publicado: (2023)

Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019)

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
por: Singh, Sonal, et al.
Publicado: (2010)

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm
por: Wilkie, Morven, et al.
Publicado: (2015)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Protective effect of inhaled corticosteroid on children with asthma with Mycoplasma pneumoniae pneumonia
por: Wei, Bing, et al.
Publicado: (2022)

Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis
por: Lee, Hyun Woo, et al.
Publicado: (2022)

Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy
por: Cheng, Shih-Lung, et al.
Publicado: (2011)

Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis
por: Yawn, Barbara P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o49rpvmm2mpp5iok167vput1dh